Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1992 Dec;29(12):892–896. doi: 10.1136/jmg.29.12.892

Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame.

L V Nicholson 1, K M Bushby 1, M A Johnson 1, J T den Dunnen 1, I B Ginjaar 1, G J van Ommen 1
PMCID: PMC1016208  PMID: 1479604

Abstract

Among 85 patients with Duchenne and Becker muscular dystrophy, 29 were found to have mutations which disrupted the open reading frame for dystrophin. Thus any dystrophin detected in this group of patients should consist of the severely truncated polypeptides that represent prematurely terminated translation products. Dystrophin was detected in blots from 17/29 biopsies and the observed sizes of the polypeptides were compared with predicted sizes calculated in two ways: if translation was terminated at the stop codon generated by each frameshifting deletion, and if the reading frame was restored and translation proceeded. In every case the observed size matched the size predicted on the basis of a restored reading frame. This was in accord with immunocytochemical labelling of scattered dystrophin positive fibres which were found on serial sections labelled with antibodies to both the rod and C-terminal domains. Thus analysis at the protein level supports genetic evidence of exon skipping as a mechanism which restores frameshifting mutations in some fibres.

Full text

PDF
892

Images in this article

894Image
on p.894
894Image
on p.894

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arahata K., Hoffman E. P., Kunkel L. M., Ishiura S., Tsukahara T., Ishihara T., Sunohara N., Nonaka I., Ozawa E., Sugita H. Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7154–7158. doi: 10.1073/pnas.86.18.7154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Augier N., Boucraut J., Léger J., Anoal M., Nicholson L. V., Voelkel M. A., Léger J. J., Pellissier J. F. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence. J Neurol Sci. 1992 Feb;107(2):233–238. doi: 10.1016/0022-510x(92)90294-u. [DOI] [PubMed] [Google Scholar]
  3. Baumbach L. L., Chamberlain J. S., Ward P. A., Farwell N. J., Caskey C. T. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology. 1989 Apr;39(4):465–474. doi: 10.1212/wnl.39.4.465. [DOI] [PubMed] [Google Scholar]
  4. Bland J. M., Altman D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307–310. [PubMed] [Google Scholar]
  5. Bulman D. E., Gangopadhyay S. B., Bebchuck K. G., Worton R. G., Ray P. N. Point mutation in the human dystrophin gene: identification through western blot analysis. Genomics. 1991 Jun;10(2):457–460. doi: 10.1016/0888-7543(91)90332-9. [DOI] [PubMed] [Google Scholar]
  6. Bulman D. E., Murphy E. G., Zubrzycka-Gaarn E. E., Worton R. G., Ray P. N. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet. 1991 Feb;48(2):295–304. [PMC free article] [PubMed] [Google Scholar]
  7. Chelly J., Gilgenkrantz H., Lambert M., Hamard G., Chafey P., Récan D., Katz P., de la Chapelle A., Koenig M., Ginjaar I. B. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell. 1990 Dec 21;63(6):1239–1248. doi: 10.1016/0092-8674(90)90419-f. [DOI] [PubMed] [Google Scholar]
  8. Davies K. E., Smith T. J., Bundey S., Read A. P., Flint T., Bell M., Speer A. Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome. J Med Genet. 1988 Jan;25(1):9–13. doi: 10.1136/jmg.25.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Den Dunnen J. T., Grootscholten P. M., Bakker E., Blonden L. A., Ginjaar H. B., Wapenaar M. C., van Paassen H. M., van Broeckhoven C., Pearson P. L., van Ommen G. J. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 1989 Dec;45(6):835–847. [PMC free article] [PubMed] [Google Scholar]
  10. England S. B., Nicholson L. V., Johnson M. A., Forrest S. M., Love D. R., Zubrzycka-Gaarn E. E., Bulman D. E., Harris J. B., Davies K. E. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature. 1990 Jan 11;343(6254):180–182. doi: 10.1038/343180a0. [DOI] [PubMed] [Google Scholar]
  11. Gillard E. F., Chamberlain J. S., Murphy E. G., Duff C. L., Smith B., Burghes A. H., Thompson M. W., Sutherland J., Oss I., Bodrug S. E. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet. 1989 Oct;45(4):507–520. [PMC free article] [PubMed] [Google Scholar]
  12. Hodgson S., Hart K., Abbs S., Heckmatt J., Rodillo E., Bobrow M., Dubowitz V. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. J Med Genet. 1989 Nov;26(11):682–693. doi: 10.1136/jmg.26.11.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hoffman E. P., Brown R. H., Jr, Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. [DOI] [PubMed] [Google Scholar]
  14. Hoffman E. P., Fischbeck K. H., Brown R. H., Johnson M., Medori R., Loike J. D., Harris J. B., Waterston R., Brooke M., Specht L. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 1988 May 26;318(21):1363–1368. doi: 10.1056/NEJM198805263182104. [DOI] [PubMed] [Google Scholar]
  15. Hoffman E. P., Kunkel L. M. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron. 1989 Jan;2(1):1019–1029. doi: 10.1016/0896-6273(89)90226-2. [DOI] [PubMed] [Google Scholar]
  16. Hoffman E. P., Morgan J. E., Watkins S. C., Partridge T. A. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci. 1990 Oct;99(1):9–25. doi: 10.1016/0022-510x(90)90195-s. [DOI] [PubMed] [Google Scholar]
  17. Koenig M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Müller C. R., Lindlöf M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct;45(4):498–506. [PMC free article] [PubMed] [Google Scholar]
  18. Koenig M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987 Jul 31;50(3):509–517. doi: 10.1016/0092-8674(87)90504-6. [DOI] [PubMed] [Google Scholar]
  19. Malhotra S. B., Hart K. A., Klamut H. J., Thomas N. S., Bodrug S. E., Burghes A. H., Bobrow M., Harper P. S., Thompson M. W., Ray P. N. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988 Nov 4;242(4879):755–759. doi: 10.1126/science.3055295. [DOI] [PubMed] [Google Scholar]
  20. Matsuo M., Masumura T., Nishio H., Nakajima T., Kitoh Y., Takumi T., Koga J., Nakamura H. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. J Clin Invest. 1991 Jun;87(6):2127–2131. doi: 10.1172/JCI115244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Monaco A. P., Bertelson C. J., Liechti-Gallati S., Moser H., Kunkel L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988 Jan;2(1):90–95. doi: 10.1016/0888-7543(88)90113-9. [DOI] [PubMed] [Google Scholar]
  22. Nicholson L. V., Davison K., Falkous G., Harwood C., O'Donnell E., Slater C. R., Harris J. B. Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J Neurol Sci. 1989 Dec;94(1-3):125–136. doi: 10.1016/0022-510x(89)90223-2. [DOI] [PubMed] [Google Scholar]
  23. Nicholson L. V., Davison K., Johnson M. A., Slater C. R., Young C., Bhattacharya S., Gardner-Medwin D., Harris J. B. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci. 1989 Dec;94(1-3):137–146. doi: 10.1016/0022-510x(89)90224-4. [DOI] [PubMed] [Google Scholar]
  24. Nicholson L. V., Johnson M. A., Davison K., O'Donnell E., Falkous G., Barron M., Harris J. B. Dystrophin or a "related protein" in Duchenne muscular dystrophy? Acta Neurol Scand. 1992 Jul;86(1):8–14. doi: 10.1111/j.1600-0404.1992.tb08046.x. [DOI] [PubMed] [Google Scholar]
  25. Nicholson L. V., Johnson M. A., Gardner-Medwin D., Bhattacharya S., Harris J. B. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol. 1990;80(3):239–250. doi: 10.1007/BF00294640. [DOI] [PubMed] [Google Scholar]
  26. Pons F., Augier N., Léger J. O., Robert A., Tomé F. M., Fardeau M., Voit T., Nicholson L. V., Mornet D., Léger J. J. A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence. FEBS Lett. 1991 Apr 22;282(1):161–165. doi: 10.1016/0014-5793(91)80468-i. [DOI] [PubMed] [Google Scholar]
  27. Roberts R. G., Barby T. F., Manners E., Bobrow M., Bentley D. R. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet. 1991 Aug;49(2):298–310. [PMC free article] [PubMed] [Google Scholar]
  28. Roberts R. G., Bobrow M., Bentley D. R. Point mutations in the dystrophin gene. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2331–2335. doi: 10.1073/pnas.89.6.2331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Récan D., Chafey P., Leturcq F., Hugnot J. P., Vincent N., Tomé F., Collin H., Simon D., Czernichow P., Nicholson L. V. Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization? J Clin Invest. 1992 Feb;89(2):712–716. doi: 10.1172/JCI115640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Scott M. O., Sylvester J. E., Heiman-Patterson T., Shi Y. J., Fieles W., Stedman H., Burghes A., Ray P., Worton R., Fischbeck K. H. Duchenne muscular dystrophy gene expression in normal and diseased human muscle. Science. 1988 Mar 18;239(4846):1418–1420. doi: 10.1126/science.2450401. [DOI] [PubMed] [Google Scholar]
  31. Vainzof M., Zubrzycka-Gaarn E. E., Rapaport D., Passos-Bueno M. R., Pavanello R. C., Pavanello-Filho I., Zatz M. Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein. J Neurol Sci. 1991 Feb;101(2):141–147. doi: 10.1016/0022-510x(91)90038-9. [DOI] [PubMed] [Google Scholar]
  32. Voit T., Stuettgen P., Cremer M., Goebel H. H. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot. Neuropediatrics. 1991 Aug;22(3):152–162. doi: 10.1055/s-2008-1071434. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES